Skip to main content
Total Market Cap: $45,736,508,969 Volume (24h): $826,464,502

Canntab Therapeutics Limited

Canntab Therapeutics Limited (PILL) logo
Rank 175
About

Focussed on providing a range of wellness products to the global cannabis market, Canntab Therapeutics has partnerships with Emblem Corp. and Cann Global Limited. Their flagship product line includes oral-dose cannabinoid and terpene blends, with a number of patents to support future developments. The company’s pharmaceutical grade formulations are aimed at treating many conditions.

Website
$0.0112
USD
0.00%
Market cap
$396,755
Total volume
$3,039
Shares outstanding
35,451,437
Reserved shares
16,510,036
Rank 175
Website
About

Focussed on providing a range of wellness products to the global cannabis market, Canntab Therapeutics has partnerships with Emblem Corp. and Cann Global Limited. Their flagship product line includes oral-dose cannabinoid and terpene blends, with a number of patents to support future developments. The company’s pharmaceutical grade formulations are aimed at treating many conditions.

Markets
Exchange Symbol Volume (24h) Volume (%) Price
The Canadian Securities Exchange
CSE
PILL
$229
7.54%
$0.0112
OTC
CTABF
Total volume
$2,810
92.46%
Stock price
$0.6160
Chart
Social media
Tweets by @@Canntab_
Canntab Therapeutics Limited

Share widget

Copy widget code
Subscribe to our newsletter